Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes
- PMID: 29311636
- PMCID: PMC5828106
- DOI: 10.1038/s41588-017-0022-7
Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes
Abstract
We have identified a variant in ADCY3 (encoding adenylate cyclase 3) associated with markedly increased risk of obesity and type 2 diabetes in the Greenlandic population. The variant disrupts a splice acceptor site, and carriers have decreased ADCY3 RNA expression. Additionally, we observe an enrichment of rare ADCY3 loss-of-function variants among individuals with type 2 diabetes in trans-ancestry cohorts. These findings provide new information on disease etiology relevant for future treatment strategies.
Conflict of interest statement
The authors report no competing financial interests.
Figures
Comment in
-
New ADCY3 Variants Dance in Obesity Etiology.Trends Endocrinol Metab. 2018 Jun;29(6):361-363. doi: 10.1016/j.tem.2018.02.004. Epub 2018 Feb 14. Trends Endocrinol Metab. 2018. PMID: 29454745
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
